Pharmaceutical Industry

Home
Sectors
Pharmaceutical Industry

25 May 2026

Diplomatic Support for Turkish Brands in the U.S. Market

As demand for natural products, wellness solutions and dietary supplements continues to grow in the U.S., Turkish brands are strengthening their visibility in the market. Within this scope, T.C. Chicago Consul General Tahir Bora Atatanır and Chicago Commercial Attaché Dr. Ahmet Samet Tekoğlu visited the Chicago headquarters of Talya Bitkisel, one of the Turkish wellness brands operating in the United States.

12 May 2026

Wellcare Unveils Three New Formulas Focused on Quality of Life

Wellcare, the consumer health brand of İLKO Pharmaceuticals, expands its portfolio with new products designed for holistic care, functional support, and nervous system health.

12 May 2026

Burak Şen Appointed as Abdi İbrahim’s Marketing Director for International Markets

Turkey's pharmaceutical leader, Abdi İbrahim, continues to strengthen its global operations by appointing Burak Şen, a seasoned executive with extensive experience in international markets, as Marketing Director for International Markets.

08 May 2026

Senior Appointment at Nobel İlaç: İlker Özer Named Information Technologies Director

Nobel İlaç, which continues its operations in line with its “Value for Health” vision, has appointed İlker Özer as Information Technologies Director. With experience gained across different sectors, Özer will contribute to the company’s digital transformation journey, data-driven organizational structure, and technology-based innovation goals.

05 May 2026

Humanis Raises Awareness on World PAH Day: Folkart Towers Illuminated with Special Lighting

Humanis carried out an awareness initiative in İzmir as part of World Pulmonary Hypertension Day on May 5 to highlight Pulmonary Arterial Hypertension, also known as high blood pressure in the lungs. During the event, Folkart Towers was illuminated with special lighting to emphasize the importance of early diagnosis in PAH, a serious condition that can often be diagnosed late because its symptoms may be confused with those of other diseases.

04 May 2026

Lokman Ecza Deposu Expands Its Next-Generation Pharmaceutical Wholesaling Model Across Türkiye

Lokman Ecza Deposu is ushering in a new era in pharmaceutical wholesaling by expanding its nationwide online sales and digital solution partnership model. With a TİTCK-approved supply infrastructure, integrated drug and vehicle tracking systems, and QR code monitoring solutions, the company aims to provide pharmacies with fast, standardized, and traceable service.

28 April 2026

Abdi İbrahim Strengthens Global Expansion

Turkey’s leading pharmaceutical company Abdi İbrahim has accelerated its global expansion strategy with two strategic leadership appointments. Natasha Poposka has been named Country Manager for North Macedonia, while Wael Okasha takes on the role in the UAE, aiming to strengthen operations in the Balkans and the Middle East.

17 April 2026

Humanis Accelerates Global Expansion: After China, the Next Target Is the U.S. Market

Humanis, the first Turkish company to export pharmaceuticals to China, is strengthening its global presence with a robust R&D infrastructure and a sustainability-driven growth strategy. The company has now set its sights on entering the U.S. market within the next 5 years, marking a critical milestone in its international expansion journey.

10 April 2026

The Key to Longevity Lies in Vascular Health: “It’s Not Age, It’s Vascular Age”

Longevity is determined not by chronological age, but by vascular health. According to Prof. Dr. Kerim Güler, when risk factors such as diabetes, obesity, and hypertension coexist, health risks can increase by up to 60 times. Experts emphasize the importance of early intervention and lifestyle management.

03 April 2026

World Medicine Maintains Leadership in Pharmaceutical Exports: 5th Consecutive Win

According to the “Stars of Export 2025” awards by İKMİB, World Medicine once again ranked first in pharmaceutical exports, reinforcing its global strength.

30 March 2026

Philips Tops European Patent Rankings in Medtech, Secures No.1 Position at EPO

Royal Philips has ranked No.1 among medical technology companies in the European Patent Office’s (EPO) 2025 Technology Dashboard. The company filed 676 medtech patent applications in 2025 alone. AI-driven innovation continues to power its strong pipeline in health technology.

30 March 2026

Eli Lilly Expands AI Drug Discovery Alliance with Insilico in Deal Worth Up to $2.75 Billion

Eli Lilly is deepening its push into AI-driven drug discovery through an expanded partnership with Insilico Medicine. The deal, valued at up to $2.75 billion, targets the development of novel oral therapies currently in preclinical stages. The collaboration aims to accelerate multi-disease targeting through advanced AI models.

‹ 1 2 3 4 ›

Turkey KKDİK Regulatory Update

Givaudan Invests in Microcaps AG to Boost Encapsulation

BASF and Bota Biosciences Launch SkinNexus™ Collag3n

ACS Green Chemistry Award Goes to Algenesis

KPX Chemical and Chinyang to Build Flexible PU Foam Recycling Plant in Korea

Turkish Chemical Sector Smashes Export Record in the First Half of the Year

Kaleseramik Brings Its "Living Spaces" Retail Concept to Baku

Evonik Announces Efficiency Program

Advertise with ChemEx World